
Dirk D. De Ruysscher-Ruysscher
Maastricht, LI 6229HX, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Isolated nodal failure in stage III non-small-cell lung cancer after proton therapy with or without durvalumab.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 10, 2025
Risk factors and prognostic factors of pleural metastases in thymic epithelial tumors: A narrative review.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 16, 2024
Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 15, 2022
Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 16, 2022
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 14, 2022
Who benefits from consolidation durvalumab in stage III non-small cell lung cancer?
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 14, 2022
Dynamics of eligibility criteria for central nervous system metastases in non-small cell lung cancer randomized clinical trials over time: A systematic review.
Journal: Critical reviews in oncology/hematology
Published: August 01, 2021
CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: May 14, 2021
The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review.
Journal: Critical reviews in oncology/hematology
Published: February 23, 2021
Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008 to 2018: A nationwide population-based study from the Netherlands.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 27, 2021
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 24, 2020
Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.
Journal: Cancer treatment reviews
Published: February 28, 2020
Last Updated: 09/26/2026